journal article·2025-09-01Open access

Bright Thermo-resilient and Promiscuous Zombie Protein for Lighting Applications

Marta Patrian, Marco Hasler, Jesús A. Banda-Vázquez, Evgenia Borisova, Juan Pablo Fuenzalida Werner, Rubén D. Costa

ACS Materials Letters· Volume 7· Issue 9

Abstract

High Resolution Image Download MS PowerPoint Slide Proteins are at the forefront of materials science, with implementations in optical, electrical, and structural materials for transformative and sustainable technologies. Within the biohybrid light-emitting diode (BioHLED) concept, replacing toxic and/or rare photon filters with classical β-barrel fluorescent proteins (FPs) that must withstand irradiation, temperature, oxidation, and dehydration stress, the question if FPs from extremophiles and/or living fossils might be better for lighting applications arises. We addressed this by introducing a thermostable prokaryotic FP, whose inherent promiscuity enables the design of tunable emitting proteins. Three milestones were reached: ( i ) a comprehensive phylogeny of phycobiliproteins from a large data set (182 proteins from 29 thermophiles) to identify the most versatile zombie-like phycobiliprotein (highly ancestral character), ( ii ) heterologous expression of this phycobiliprotein (SPritZ) in Escherichia coli and further enhancement via rational mutagenesis into a brighter and more thermal-resilient variant (eSPritZ), and ( iii ) 2.5-fold stable BioHLEDs comparing SPritZ vs eSPritZ in hydroxypropyl cellulose coatings.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Fluorescence Microscopy Techniques · Photosynthetic Processes and Mechanisms · Protein Structure and Dynamics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Technical University of Munich, Campus Straubing for Sustainability and Biotechnology, Chair of Biogenic Functional Materials, Schulgasse, 22, Straubing 94315, Germany

Funding

H2020 Marie Sklodowska-Curie Actions · Horizon 2020 Framework Programme

References (48)

Show source-provided references
1. 10.1038/s41563-020-00883-310.1038/s41563-020-00883-3 ↗
2. 10.1038/s41563-023-01611-310.1038/s41563-023-01611-3 ↗
3. 10.1002/adfm.20170701110.1002/adfm.201707011 ↗
4. 10.1002/aenm.20217016910.1002/aenm.202170169 ↗
5. 10.1038/s41563-020-00857-510.1038/s41563-020-00857-5 ↗
6. 10.1038/s41578-021-00350-810.1038/s41578-021-00350-8 ↗
7. 10.1016/j.heliyon.2023.e2301110.1016/j.heliyon.2023.e23011 ↗
8. 10.1002/adma.20150234910.1002/adma.201502349 ↗
9. 10.1002/adfm.20241292110.1002/adfm.202412921 ↗
10. 10.1021/acs.nanolett.0c0032410.1021/acs.nanolett.0c00324 ↗
11. 10.1088/0957-4484/27/45/45LT0110.1088/0957-4484/27/45/45LT01 ↗
12. 10.1039/C9TC05342E10.1039/C9TC05342E ↗
13. 10.1002/advs.20230006910.1002/advs.202300069 ↗
14. 10.1002/adma.20237034610.1002/adma.202370346 ↗
15. 10.1021/acs.biomac.2c0095710.1021/acs.biomac.2c00957 ↗
16. 10.1021/acsnano.3c0528410.1021/acsnano.3c05284 ↗
17. 10.1002/adma.20231103110.1002/adma.202311031 ↗
18. 10.3390/resources304061410.3390/resources3040614 ↗
19. 10.1002/adma.20210458110.1002/adma.202104581 ↗
20. 10.3389/fevo.2023.111276410.3389/fevo.2023.1112764 ↗
21. 10.1007/s13205-023-03733-610.1007/s13205-023-03733-6 ↗
22. 10.1016/j.freeradbiomed.2019.05.00710.1016/j.freeradbiomed.2019.05.007 ↗
23. 10.1016/j.ijbiomac.2021.11.02210.1016/j.ijbiomac.2021.11.022 ↗
24. 10.1186/s12934-019-1100-610.1186/s12934-019-1100-6 ↗
25. 10.1002/adfm.20230182010.1002/adfm.202301820 ↗
26. 10.1073/pnas.051009810310.1073/pnas.0510098103 ↗
27. 10.1016/j.sbi.2009.08.00310.1016/j.sbi.2009.08.003 ↗
28. 10.1016/j.biochi.2018.05.00610.1016/j.biochi.2018.05.006 ↗
29. 10.1021/acssynbio.1c0051210.1021/acssynbio.1c00512 ↗
30. 10.1073/pnas.220790411910.1073/pnas.2207904119 ↗
31. 10.1515/hsz-2015-015810.1515/hsz-2015-0158 ↗
32. 10.1006/jmbi.1995.020310.1006/jmbi.1995.0203 ↗
33. 10.3390/ijms1808169110.3390/ijms18081691 ↗
34. 10.1038/ismej.2016.17310.1038/ismej.2016.173 ↗
35. 10.1038/nature0330610.1038/nature03306 ↗
36. 10.1093/molbev/msl20610.1093/molbev/msl206 ↗
37. 10.1073/pnas.95.15.842010.1073/pnas.95.15.8420 ↗
38. 10.1016/j.bej.2017.06.00110.1016/j.bej.2017.06.001 ↗
39. 10.1016/j.jbiosc.2008.11.01410.1016/j.jbiosc.2008.11.014 ↗
40. 10.1007/s00253-003-1232-810.1007/s00253-003-1232-8 ↗
41. 10.1016/S0014-5793(00)01245-X10.1016/S0014-5793(00)01245-X ↗
42. 10.1371/journal.pone.017922910.1371/journal.pone.0179229 ↗
43. 10.1038/s41586-021-03819-210.1038/s41586-021-03819-2 ↗
44. 10.1038/nmeth.393510.1038/nmeth.3935 ↗
45. 10.1016/j.jsb.2018.09.01310.1016/j.jsb.2018.09.013 ↗
46. 10.1007/s11120-016-0259-510.1007/s11120-016-0259-5 ↗
47. 10.1021/acs.molpharmaceut.0c0033010.1021/acs.molpharmaceut.0c00330 ↗
48. 10.1562/2005-05-26-RA-54410.1562/2005-05-26-RA-544 ↗